vTv Therapeutics (VTVT) Assets Average (2015 - 2026)
vTv Therapeutics (VTVT) posted Assets Average of $94.4 million for Q1 2026, little changed sequentially from $94.7 million in Q4 2025, and up 168.46% YoY from $35.1 million in Q1 2025.
vTv Therapeutics (VTVT) Assets Average (2015 - 2026) Analysis & Trends
vTv Therapeutics has reported Assets Average for 12 years, with the latest figure at $94.4 million in Q1 2026.
- Quarterly Assets Average rose 168.46% year-over-year to $94.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.4 million (up 168.46% YoY) and the FY2025 annual result came in at $64.1 million, up 160.05% from the prior year.
- Assets Average was little changed at $94.4 million in Q1 2026 per VTVT's latest filing, from $94.7 million in the prior quarter.
- Over five years, Assets Average peaked at $94.7 million in Q4 2025 and troughed at $13.0 million in Q4 2023.
- A 5-year average of $40.9 million and a median of $34.4 million in 2022 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2024: Assets Average sank 62.27% in 2023, then soared 213.89% in 2024.
- Over 5 years, Assets Average stood at $34.4 million in 2022, then tumbled by 62.27% to $13.0 million in 2023, then jumped by 213.89% to $40.7 million in 2024, then soared by 132.58% to $94.7 million in 2025, then slipped by 0.36% to $94.4 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $94.4 million, $94.7 million, and $63.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - | 93.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.20 Mn |
| Mar 31, 2026 | 94.36 Mn |
| Dec 31, 2025 | 94.70 Mn |
| Sep 30, 2025 | 62.97 Mn |
| Jun 30, 2025 | 29.24 Mn |
| Mar 31, 2025 | 35.15 Mn |
| Dec 31, 2024 | 40.72 Mn |
| Sep 30, 2024 | 44.81 Mn |
| Jun 30, 2024 | 50.32 Mn |
| Mar 31, 2024 | 32.60 Mn |
| Dec 31, 2023 | 12.97 Mn |
| Sep 30, 2023 | 18.68 Mn |
| Jun 30, 2023 | 25.63 Mn |
| Mar 31, 2023 | 31.03 Mn |
| Dec 31, 2022 | 34.38 Mn |
| Sep 30, 2022 | 36.25 Mn |
| Jun 30, 2022 | 28.59 Mn |
| Mar 31, 2022 | 22.83 Mn |
| Dec 31, 2021 | 28.45 Mn |
| Sep 30, 2021 | 26.55 Mn |